Lance Bass, a former member of the band *NSYNC, was initially diagnosed with Type 2 diabetes but later found out he actually has latent autoimmune diabetes of adults (LADA), also known as Type 1.5 diabetes. LADA exhibits features of both Type 1 and Type 2 diabetes and it is typically diagnosed in adults over the age of 30. Symptoms of LADA include frequent thirst, increased urination, unexplained weight loss, blurred vision, tingling in the hands or feet, weakness, and fatigue. Bass shared his new diagnosis on Instagram while promoting Dexcom G7, a continuous glucose monitor.
Diabetes is a prevalent health condition affecting around 38 million Americans. Type 1 diabetes is usually diagnosed in childhood or adolescence, characterized by little to no insulin production by the pancreas. On the other hand, Type 2 diabetes occurs when the pancreas does not produce enough insulin or when insulin is not used effectively, resulting in high blood sugar levels. LADA is a slow-developing condition where the immune system mistakenly attacks insulin-producing cells in the pancreas, causing difficulties in regulating blood sugar levels.
LADA is often misdiagnosed because of its similarities to Type 1 and Type 2 diabetes. Only with testing for autoimmune antibodies can a proper diagnosis of LADA be made. As many as 10% of individuals diagnosed with Type 2 diabetes may actually have LADA. Treatment for LADA typically involves lifestyle changes such as regular exercise, healthy diet choices, weight management, and quitting smoking. Medications to lower blood sugar levels may be prescribed initially, but eventually, insulin shots are needed as the body’s insulin production decreases.
Bass explained that after modifying his diet, exercise routine, and using a continuous glucose monitor, he felt better managing his diabetes. The Dexcom G7 monitor allows individuals to track their blood sugar levels continuously, providing valuable information for managing the condition effectively. With proper management, individuals with LADA can lead healthy lives. As understanding of LADA improves, more individuals could be accurately diagnosed and receive appropriate treatment to manage their condition effectively.
Overall, LADA is a specific form of diabetes that combines features of Type 1 and Type 2 diabetes, typically affecting adults over the age of 30. The immune system mistakenly attacks insulin-producing cells in the pancreas, leading to difficulties in controlling blood sugar levels. Symptoms can mimic those of Type 1 and Type 2 diabetes, making diagnosis challenging without specific testing for autoimmune antibodies. Proper management of LADA involves lifestyle changes, medications to lower blood sugar, and eventually, insulin shots as the body’s ability to produce insulin diminishes. Continuous glucose monitoring can be a valuable tool in managing LADA and ensuring blood sugar levels are kept within a healthy range.
